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Background: Stent platform characteristics, including material and design, influence both periprocedural and late performance. Recent reports 
have suggested susceptibility of novel thin-strut coronary stents to incur longitudinal stent deformation during or following deployment. This analysis 
focuses on the ION (Element) stent.
Methods: Quantitative angiographic analysis (QCA) by a blinded core lab was performed on 2403 stents from the PERSEUS Workhorse (WH) and 
PLATINUM WH trials. The ratio of QCA measured to nominal stent length was compared between trial arms to evaluate longitudinal stent deformation 
(Figure). A ratio >1.0 suggested stent elongation and <1.0 suggested compression.
Results: Overall, QCA: nominal stent length ratio averaged 0.95 ± 0.07 in the TAXUS Express arm and 0.94 ± 0.06 in the ION arm of the PERSEUS 
WH trial (P=0.16, Figure). In the PLATINUM WH trial, the mean ratio in the PROMUS cohort was smaller (0.92 ± 0.09) than PROMUS Element (0.94 
±0.08; P=0.004, Figure). The maximum and minimum values in each treatment cohort of PERSEUS and PLATINUM were similar (Figure).
Conclusion: Systematic analysis by an independent angiographic core lab of more than 2400 stents implanted in patients enrolled in 2 large 
multicenter randomized trials demonstrates no significant differences in longitudinal stent deformation between ION and TAXUS Express stents, or 
between PROMUS Element and PROMUS stents in the studied patient populations.
 
